Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV
- PMID: 24355031
- DOI: 10.1016/S1473-3099(13)70359-1
Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV
Comment on
-
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.Lancet Infect Dis. 2013 Jul;13(7):597-605. doi: 10.1016/S1473-3099(13)70149-X. Epub 2013 Jun 12. Lancet Infect Dis. 2013. PMID: 23768747 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
